Beijing Guolian Chenghui Pharmaceutical Technology

Beijing Guolian Chenghui Pharmaceutical Technology is a China-based Contract Research Organization (CRO) that provides comprehensive clinical development services to the pharmaceutical and biotechnology sectors. The company specializes in clinical trial management for Phase I through IV studies, with a particular emphasis on bioequivalence (BE) testing and regulatory affairs. Guolian Chenghui assists clients in navigating the complex National Medical Products Administration (NMPA) registration process, offering expertise in medical writing, data management, and statistical analysis. By maintaining a broad network of clinical trial sites across China, the firm facilitates efficient drug development and market entry for both domestic and international pharmaceutical companies.